Imperagen raises $6.7M Seed (United Kingdom, May 2026)

Imperagen raises £5 million to use quantum physics, AI on enzyme engineering - TechCrunch

Imperagen is a biotech company focused on enzyme engineering, utilizing quantum physics and AI to enhance the speed and efficiency of enzyme development. The company aims to revolutionize the traditional trial-and-error methods in enzyme engineering, making the process faster and more commercially viable for various industries, including pharmaceuticals and agriculture.

Imperagen raises £5 million to use quantum physics, AI on enzyme engineering  TechCrunch